Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bartkowiak

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Der Urologe. Ausg. A|June 18, 2015
[Adjuvant radiotherapy in lymph-node-positive prostate cancer with low tumor burden after radical prostatectomy : Multicenter randomized phase III trial on the effect of adjuvant radio therapy in patients with prostate cancer with or without positive margins after radical prostatectomy (RP) and lymph node metastasis with low tumor burden (micrometastases, ≤ 2 lymph node macrometastases). ART-2 trial AP 61/11 of the AUO]H Rexer, D Bartkowiak
Der Urologe. Ausg. A|July 2, 2017
[Adjuvant radiotherapy for lymph-node-positive prostate cancer with low tumor load after radical prostatectomy : Multicenter randomized phase III study of the effect of adjuvant radiotherapy in patients with prostate cancer with or without a positive margin after radical prostatectomy (RP) and lymph node metastasis with low tumor load (micrometastases, ≤ 2 lymph node macrometastases). ART-2 - study AP 61/10 of the AUO]H Rexer, D Bartkowiak
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 1996
[Prognostic significance of proliferative and apoptotic fractions in low grade follicular non-Hodgkin's lymphoma]D Bartkowiak, E M Röttinger
International Journal of Radiation Biology|September 23, 1997
Stable radiobiological features in a genetically unstable glioblastoma cell lineD Bartkowiak, E M Röttinger
Clinical Chemistry|March 1, 1989
Rheumatoid factors determined by fluorescence immunoassay: comparison with qualitative and quantitative methodsA B Carpenter, C D Bartkowiak
Brain Sciences|March 27, 2026
Neuro-Transcriptomic Responses to Polypharmacological Agents in <i>Danio rerio</i>: Implications for Translational Drug Repurposing in Neurodevelopmental DisordersAlexander D Bartkowiak, Marie R Mooney
Cancer Chemotherapy and Pharmacology|January 1, 1992
Dose dependence of the cytokinetic and cytotoxic effects of epirubicin in vitroD Bartkowiak, J Hemmer, E Röttinger
Aktuelle Urologie|February 7, 2015
[Adjuvant vs. salvage radiotherapy after radical prostatectomy]D Bartkowiak, A J Schrader, T Wiegel
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 5, 1999
Differential proliferation dependence of alpha and beta damage in X-irradiated Chinese hamster cellsD Bartkowiak, W Nothdurft, E M Röttinger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 7, 2012
Radiotherapy after radical prostatectomy: immediate or early delayed?D Bottke, D Bartkowiak, M Schrader, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Der Urologe. Ausg. A|June 18, 2015
[Adjuvant radiotherapy in lymph-node-positive prostate cancer with low tumor burden after radical prostatectomy : Multicenter randomized phase III trial on the effect of adjuvant radio therapy in patients with prostate cancer with or without positive margins after radical prostatectomy (RP) and lymph node metastasis with low tumor burden (micrometastases, ≤ 2 lymph node macrometastases). ART-2 trial AP 61/11 of the AUO]H Rexer, D Bartkowiak
Der Urologe. Ausg. A|July 2, 2017
[Adjuvant radiotherapy for lymph-node-positive prostate cancer with low tumor load after radical prostatectomy : Multicenter randomized phase III study of the effect of adjuvant radiotherapy in patients with prostate cancer with or without a positive margin after radical prostatectomy (RP) and lymph node metastasis with low tumor load (micrometastases, ≤ 2 lymph node macrometastases). ART-2 - study AP 61/10 of the AUO]H Rexer, D Bartkowiak
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 1996
[Prognostic significance of proliferative and apoptotic fractions in low grade follicular non-Hodgkin's lymphoma]D Bartkowiak, E M Röttinger
International Journal of Radiation Biology|September 23, 1997
Stable radiobiological features in a genetically unstable glioblastoma cell lineD Bartkowiak, E M Röttinger
Clinical Chemistry|March 1, 1989
Rheumatoid factors determined by fluorescence immunoassay: comparison with qualitative and quantitative methodsA B Carpenter, C D Bartkowiak
Brain Sciences|March 27, 2026
Neuro-Transcriptomic Responses to Polypharmacological Agents in <i>Danio rerio</i>: Implications for Translational Drug Repurposing in Neurodevelopmental DisordersAlexander D Bartkowiak, Marie R Mooney
Cancer Chemotherapy and Pharmacology|January 1, 1992
Dose dependence of the cytokinetic and cytotoxic effects of epirubicin in vitroD Bartkowiak, J Hemmer, E Röttinger
Aktuelle Urologie|February 7, 2015
[Adjuvant vs. salvage radiotherapy after radical prostatectomy]D Bartkowiak, A J Schrader, T Wiegel
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 5, 1999
Differential proliferation dependence of alpha and beta damage in X-irradiated Chinese hamster cellsD Bartkowiak, W Nothdurft, E M Röttinger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 7, 2012
Radiotherapy after radical prostatectomy: immediate or early delayed?D Bottke, D Bartkowiak, M Schrader, et al.
Pageof 3